Abstract
In a double-blind, cross-over trial with metronidazole (Flagyl®) 400 mg twice daily and placebo given to suitably adjusted ileostomy operated patients during two week periods, no significant reduction could be demonstrated in gaseous discomfort as measured by the number of bag emptyings per day, as well as gaseous symptoms in the form of the passage of flatulence from the stoma and borborygmi.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Finegold SM, Sutter VL, Boyle JD, Shimada K (1970) The normal flora of ileostomy and transverse colostomy effluents. J Inf Dis 122:376–381
Gorbach SL, Nahas L, Weinstein L (1967) Studies of intestinal microflora. The microflora of ileostomy effluent. Gastroenterology 53:874–880
Brogden RN, Heel RC, Speight TM, Avery GS (1978) Metronidazole in anaerobic infections. Drugs 16:387–417
McLeod RS (1985) Patient evaluation of the conventional ileostomy. Dis Colon Rectum 28:152–154
Feinstein AR (1975) Clinical biostatistics. The other side of statistical significance: alpha, beta, delta, and the calculation of sample size. Clin Pharmacol Ther 18:491–505
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Funder, V., Ottsen, B. & Kjærgaard, J. Metronidazole versus placebo in the treatment of gaseous discomfort in patients having an ileostomy. Int J Colorect Dis 3, 36–37 (1988). https://doi.org/10.1007/BF01649681
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01649681